share_log

Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by GPS Wealth Strategies Group LLC

Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by GPS Wealth Strategies Group LLC

Teladoc Health,Inc.(纽约证券交易所代码:TDOC)由GPS Wealth Strategy Group LLC出售的股票
Defense World ·  2022/09/30 06:02

GPS Wealth Strategies Group LLC cut its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 63.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 943 shares of the health services provider's stock after selling 1,627 shares during the period. GPS Wealth Strategies Group LLC's holdings in Teladoc Health were worth $31,000 as of its most recent SEC filing.

GPS Wealth Strategy Group LLC最近提交给美国证券交易委员会(Securities&Exchange Commission)的文件显示,该公司第二季度将Teladoc Health,Inc.(纽约证券交易所代码:TDOC-GET评级)的股票减持了63.3%。该公司在此期间出售了1,627股后,持有这家医疗服务提供商的943股股票。截至最近提交给美国证券交易委员会的文件,GPS Wealth Strategy Group LLC持有的Teladoc Health股份价值31,000美元。

A number of other institutional investors have also recently modified their holdings of TDOC. ETF Managers Group LLC boosted its holdings in Teladoc Health by 4.9% in the 4th quarter. ETF Managers Group LLC now owns 3,756 shares of the health services provider's stock worth $354,000 after buying an additional 177 shares during the last quarter. Eaton Vance Management boosted its holdings in Teladoc Health by 97.3% in the 4th quarter. Eaton Vance Management now owns 100,752 shares of the health services provider's stock worth $9,216,000 after buying an additional 49,699 shares during the last quarter. Itau Unibanco Holding S.A. boosted its holdings in Teladoc Health by 24.9% in the 4th quarter. Itau Unibanco Holding S.A. now owns 808 shares of the health services provider's stock worth $76,000 after buying an additional 161 shares during the last quarter. Cubist Systematic Strategies LLC boosted its holdings in Teladoc Health by 501.6% in the 4th quarter. Cubist Systematic Strategies LLC now owns 65,583 shares of the health services provider's stock worth $6,022,000 after buying an additional 54,681 shares during the last quarter. Finally, Credit Agricole S A boosted its holdings in Teladoc Health by 63.3% in the 4th quarter. Credit Agricole S A now owns 24,991 shares of the health services provider's stock worth $2,295,000 after buying an additional 9,684 shares during the last quarter. 92.46% of the stock is currently owned by institutional investors and hedge funds.

其他一些机构投资者最近也调整了对TDOC的持股。ETF Manager Group LLC在第四季度将其在Teladoc Health的持股增加了4.9%。ETF Manager Group LLC目前持有这家医疗服务提供商3,756股股票,价值354,000美元,此前该公司在上个季度又购买了177股。伊顿·万斯管理公司在第四季度增持了Teladoc Health 97.3%的股份。伊顿·万斯管理公司(Eaton Vance Management)在上个季度额外购买了49,699股后,现在拥有这家医疗服务提供商价值9,216,000美元的100,752股票。Itau Unibanco Holding S.A.在第四季度将其在Teladoc Health的持股增加了24.9%。Itau Unibanco Holding S.A.在上个季度又购买了161股,现在拥有808股这家医疗服务提供商的股票,价值7.6万美元。Cubist Systems Strategy LLC在第四季度将其在Teladoc Health的持股增加了501.6%。Cubist Systems Strategy LLC现在拥有这家医疗服务提供商的65,583股票,价值6,022,000美元,此前在上个季度又购买了54,681股票。最后,法国农业信贷银行在第四季度增持了Teladoc Health 63.3%的股份。法国农业信贷银行现在拥有24,991股这家医疗服务提供商的股票,价值2,295,000美元,此前在上个季度又购买了9,684股。92.46%的股票目前由机构投资者和对冲基金持有。

Get
到达
Teladoc Health
Teladoc Health
alerts:
警报:

Analyst Upgrades and Downgrades

分析师升级和下调评级

Several research firms recently issued reports on TDOC. StockNews.com upgraded Teladoc Health to a "sell" rating in a report on Tuesday, August 9th. SVB Leerink lowered their target price on Teladoc Health from $35.00 to $34.00 and set a "market perform" rating on the stock in a report on Thursday, July 28th. Royal Bank of Canada lowered their target price on Teladoc Health from $53.00 to $35.00 in a report on Wednesday. Needham & Company LLC cut Teladoc Health from a "buy" rating to a "hold" rating in a report on Thursday, July 28th. Finally, Truist Financial initiated coverage on Teladoc Health in a report on Wednesday, September 7th. They set a "hold" rating and a $35.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, twenty-four have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $64.13.

几家研究公司最近发布了关于TDOC的报告。在8月9日星期二的一份报告中,StockNews.com将Teladoc Health的评级上调至“卖出”。SVB Leerink在7月28日周四的一份报告中将其对Teladoc Health的目标价从35.00美元下调至34.00美元,并对该股设定了“市场表现”评级。加拿大皇家银行在周三的一份报告中将Teladoc Health的目标价从53.00美元下调至35.00美元。Needham&Company LLC在7月28日星期四的一份报告中将Teladoc Health的评级从“买入”下调至“持有”。最后,Truist Financial在9月7日星期三的一份报告中发起了对Teladoc Health的报道。他们为该股设定了“持有”评级和35.00美元的目标价。两名投资分析师对该股的评级为卖出,24名分析师给予持有评级,5名分析师对该股给予买入评级。根据MarketBeat的数据,该股目前的平均评级为持有,共识目标价为64.13美元。

Insider Activity

内幕活动

In related news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the transaction, the senior vice president now owns 26,408 shares of the company's stock, valued at $990,300. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through
在相关新闻中,高级副总裁Daniel·特伦彻在8月17日星期三的一次交易中出售了1,000股该股。这只股票的平均售价为37.50美元,总价值为37500.00美元。交易完成后,高级副总裁现在持有该公司26,408股股票,价值990,300美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过
. In other Teladoc Health news, insider Arnnon Geshuri sold 4,098 shares of the firm's stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $34.27, for a total transaction of $140,438.46. Following the transaction, the insider now owns 76,182 shares of the company's stock, valued at $2,610,757.14. The sale was disclosed in a filing with the SEC, which is accessible through
。在Teladoc Health的其他新闻中,内部人士Arnnon Geshuri在一笔日期为8月26日星期五的交易中出售了4098股该公司股票。该股以34.27美元的平均价格出售,总成交金额为140,438.46美元。交易完成后,这位内部人士现在拥有76,182股该公司股票,价值2,610,757.14美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过
. Also, SVP Daniel Trencher sold 1,000 shares of the firm's stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the transaction, the senior vice president now directly owns 26,408 shares in the company, valued at approximately $990,300. The disclosure for this sale can be found
。此外,高级副总裁Daniel·特伦彻在一笔日期为8月17日星期三的交易中出售了1,000股该公司股票。这只股票的平均售价为37.50美元,总价值为37500.00美元。交易完成后,高级副总裁现在直接持有该公司26,408股股份,价值约990,300美元。关于这次销售的披露可以找到
. Over the last three months, insiders have sold 7,318 shares of company stock worth $255,321. Corporate insiders own 1.55% of the company's stock.
。在过去的三个月里,内部人士已经出售了7318股公司股票,价值255,321美元。企业内部人士持有该公司1.55%的股份。

Teladoc Health Price Performance

Teladoc健康性价比

Shares of NYSE TDOC opened at $26.23 on Friday. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25. Teladoc Health, Inc. has a 12-month low of $25.95 and a 12-month high of $156.82. The business's fifty day simple moving average is $33.75 and its 200-day simple moving average is $41.67.

上周五,纽约证交所TDOC的股价开盘报26.23美元。该公司的流动比率为3.38,速动比率为3.22,债务权益比率为0.25。Teladoc Health,Inc.的股价为25.95美元,为12个月低点,12个月高位为156.82美元。该业务的50日简单移动均线切入位为33.75美元,200日简单移动均线切入位为41.67美元。

Teladoc Health (NYSE:TDOC – Get Rating) last announced its quarterly earnings data on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.71) by $0.27. The business had revenue of $592.38 million for the quarter, compared to analysts' expectations of $586.86 million. Teladoc Health had a negative return on equity of 2.04% and a negative net margin of 441.94%. As a group, equities research analysts expect that Teladoc Health, Inc. will post -1.54 EPS for the current year.

Teladoc Health(纽约证券交易所代码:TDOC-GET Rating)最近一次公布季度收益数据是在7月27日星期三。这家医疗服务提供商公布了本季度每股收益(EPS)(0.44美元),比普遍预期的(0.71美元)高出0.27美元。该业务当季营收为5.9238亿美元,高于分析师预期的5.8686亿美元。Teladoc Health的净资产回报率为负2.04%,净利润率为负441.94%。作为一个整体,股票研究分析师预计Teladoc Health,Inc.本年度每股收益将达到1.54美元。

Teladoc Health Profile

Teladoc健康配置文件

(Get Rating)

(获取评级)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Teladoc Health,Inc.在美国和国际上提供虚拟医疗服务。该公司提供一系列服务和解决方案,涵盖非紧急、间歇性、慢性和复杂的医疗状况,包括糖尿病、高血压、慢性肾脏疾病、癌症、充血性心力衰竭和精神健康状况。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
  • Humana Proves Vertically Integrated Healthcare Works
  • 2 Casino Stocks Worth Taking a Look At
  • What Cintas Can Teach Investors About This Bear Market?
  • This Small-Cap Healthcare Name Is Outperforming Its Index
  • Blackberry Stock Declines As Results Come In Lukewarm Once Again
  • 免费获取StockNews.com关于Teladoc Health(TDOC)的研究报告
  • Humana证明垂直整合的医疗保健工作
  • 值得一看的2只赌场股票
  • 关于这个熊市,Cintas能教给投资者什么?
  • 这家小盘股医疗保健公司的表现好于其指数
  • 黑莓股价下跌,业绩再次不温不火

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Get Rating).

想看看其他对冲基金持有TDOC的情况吗?访问HoldingsChannel.com获取Teladoc Health,Inc.(纽约证券交易所代码:TDOC-GET Rating)的最新13F文件和内幕交易信息。

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

接受Teladoc健康日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Teladoc Health和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发